| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/23/2009 | WO2009111529A3 Method of treating polycystic kidney disease |
| 12/23/2009 | WO2009088402A3 Identification of bacterial autoinducer and use in treating bacterial pathogenicity |
| 12/23/2009 | WO2009043191A8 Method for producing macro-porous materials |
| 12/23/2009 | WO2009029272A3 Epitope vaccine for prevention and reversion of ad pathology |
| 12/23/2009 | WO2009019612A3 Lentiviral gene transfer vectors and their medicinal applications |
| 12/23/2009 | WO2008091643A3 Evaluating synergy of combinations comprising an antibody in immune suppressive pathways concurrent to immunotherapy |
| 12/23/2009 | WO2008073300A3 Monoclonal antibodies against angptl3 |
| 12/23/2009 | WO2001000790A9 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| 12/23/2009 | WO2000015247A8 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 12/23/2009 | EP2135952A2 Cripto antagonism of activin and TGF-beta signaling |
| 12/23/2009 | EP2135942A1 Method for suppressing immune system response to transplanted tissue or cells |
| 12/23/2009 | EP2135881A1 Antibodies binding to the tumour associated antigen TAT10772 for the diagnosis and treatment of tumor |
| 12/23/2009 | EP2135880A1 Anti-prion protein antibody fragment |
| 12/23/2009 | EP2135878A1 Tumor-associated peptide binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 12/23/2009 | EP2135876A2 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotherapy |
| 12/23/2009 | EP2135619A1 Humanized anti-CCR2 antibodies and methods of use therefor |
| 12/23/2009 | EP2134749A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 12/23/2009 | EP2134746A1 Monoclonal human tumor-specific antibody |
| 12/23/2009 | EP2134373A2 Nuclear targeting sequences |
| 12/23/2009 | EP2134366A2 Products for prophylaxis and/or treatment of viral diseases and method of making and using same |
| 12/23/2009 | EP2134365A1 Compositions and methods for inhibiting tumor cell growth |
| 12/23/2009 | EP2134364A2 Treatment of carcinomas with a combination of egf-pathway and telomerase inhibitors |
| 12/23/2009 | EP2134363A2 Compositions and methods for treatment of cervical cancer |
| 12/23/2009 | EP2134359A2 Use of an avirulent bordetella mutant as a live vaccine vector |
| 12/23/2009 | EP2134358A1 Compositions and methods for targeted ablation of mutational escape of targeted therapies for cancer |
| 12/23/2009 | EP2134356A2 Negative genetic regulation of cancer cell renewal in synergy with notch- or numb-specific immunotherapy |
| 12/23/2009 | EP1687329B1 Optimized expression of hpv 58 l1 in yeast |
| 12/23/2009 | EP1575979B1 West nile virus vaccine |
| 12/23/2009 | EP1483297B1 Antibodies derived from anti ed-b l19 and targeting tumor vasculature |
| 12/23/2009 | EP1425295B1 Modified peptides and their use for the treatment of autoimmune diseases |
| 12/23/2009 | EP1421174B1 Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof |
| 12/23/2009 | EP1274861B1 Compositions and methods for identifying and targeting cancer cells |
| 12/23/2009 | EP1107782B1 Oral vaccine compositions |
| 12/23/2009 | EP1094837B1 Porcine circovirus and parvovirus vaccine |
| 12/23/2009 | CN101611320A Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the diagnosis of inflammatory intestinal diseases and chronic pan |
| 12/23/2009 | CN101611060A Intranasal delivery of polypeptides and proteins |
| 12/23/2009 | CN101611059A Antibodies against insulin-like growth factor I receptor and uses thereof |
| 12/23/2009 | CN101611058A PRLR-specific antibody and uses thereof |
| 12/23/2009 | CN101611057A Antibody molecules for human il-17 |
| 12/23/2009 | CN101611055A Human antibodies to human DELTA like ligand 4 |
| 12/23/2009 | CN101610788A Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 12/23/2009 | CN101610787A Method for replicating influenza virus in culture |
| 12/23/2009 | CN101610786A Prevention and treatment of sub-clinical PCVD |
| 12/23/2009 | CN101610785A 多价肺炎球菌多糖-蛋白质缀合物组合物 Multivalent pneumococcal polysaccharide - protein conjugate composition |
| 12/23/2009 | CN101607984A Multi-copy polypeptide and application thereof |
| 12/23/2009 | CN101607983A Encephalitis B virus PrM/M protein B cell antigen epitope polypeptide and applications |
| 12/23/2009 | CN101607085A Method for preparing triple inactivated vaccine of chicken infectious bursal disease |
| 12/23/2009 | CN101607084A Method for preparing bigeminy inactivated vaccine of newcastledisease and H9 hypotype bird flu |
| 12/23/2009 | CN101607083A Method for preparing tetrad inactivated vaccine of bird flu |
| 12/23/2009 | CN101607082A Method for preparing inactivated vaccine of porcine reproductive and respiratory syndrome |
| 12/23/2009 | CN101607081A brucella vaccine and method for preparing antigen protein used for same |
| 12/23/2009 | CN100572540C Tuberculosis vaccines including recombinant BCG strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 12/23/2009 | CN100572532C Duck plague vaccines and special strains therefor |
| 12/23/2009 | CN100572530C Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitro |
| 12/23/2009 | CN100572392C 截短tau蛋白 Truncated tau protein |
| 12/23/2009 | CN100571786C Vaccine for preventing and/or treating autoimmune disease |
| 12/23/2009 | CN100571775C Avian influenza virus marking vaccine, preparation process and application thereof |
| 12/23/2009 | CN100571774C Typhoid, paratyphoid envelope protein vaccine |
| 12/23/2009 | CN100571715C Compositions containing bioactive materials, methods of preparation and treatment |
| 12/23/2009 | CA2735724A1 Compositions and methods for treating influenza |
| 12/23/2009 | CA2728739A1 Compositions, methods, and kits for eliciting an immune response |
| 12/23/2009 | CA2728459A1 Immunogenic peptides derived from the midkine protein, as an anticancer vaccine |
| 12/23/2009 | CA2728308A1 Compositions and methods of use of orf1358 from beta-hemolytic streptococcal strains |
| 12/23/2009 | CA2728276A1 Combination therapies against cancer |
| 12/23/2009 | CA2728268A1 Cdca1 epitope peptides and vaccines containing the same |
| 12/23/2009 | CA2728258A1 Compositions and methods of use of orf 554 from beta hemolytic streptococcal strains |
| 12/23/2009 | CA2728233A1 Novel fusion proteins and use thereof for preparing hepatitis c vaccines |
| 12/23/2009 | CA2728060A1 Modified beta-lactoglobulins for immunotherapy of milk allergy |
| 12/23/2009 | CA2727937A1 Immunoglobulins with reduced aggregation |
| 12/23/2009 | CA2727909A1 Anti-prion protein antibody fragment |
| 12/23/2009 | CA2724549A1 Biomarker for selecting patients and related methods |
| 12/23/2009 | CA2724257A1 Antibodies to il-6 and their uses |
| 12/22/2009 | US7635767 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
| 12/22/2009 | US7635757 Nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro |
| 12/22/2009 | US7635752 Ablated SLAM-Dependent Entry |
| 12/22/2009 | US7635749 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 12/22/2009 | US7635722 Chemical induced intracellular hyperthermia |
| 12/22/2009 | US7635688 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides |
| 12/22/2009 | US7635592 Generating tissue solid support; obtain matrix intensifying particles, couple to solid support, incubate with cell and growth factor, propagate tissue |
| 12/22/2009 | US7635568 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 12/22/2009 | US7635492 isolated from fusarium; fat mimetics; for use in yoghurt, milk drinks, low fat spreads, and snack foods; for use in foods for treatment of joint mobility disorders, reducing fat uptake, lowering cholesterol, immune function stimulation, use on a pre-biotic and/or for affecting satiety |
| 12/22/2009 | US7635487 Nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof from S. pneumoniae; for prevention and treatment of bacterial infections caused by Streptococcus pneumoniae |
| 12/22/2009 | US7635486 Where lipidation thereof is from expression of first nucleic acid sequence and protein portion thereof is from expression of second nucleic acid sequence and first and second sequences do not naturally occur together, such as a lipoprotein where first sequence encodes Borrelia lipoprotein, second, PsaA |
| 12/22/2009 | US7635485 Method of accelerated vaccination against Ebola viruses |
| 12/22/2009 | US7635484 Clostridial peptide for preventing or reducing immunoresistance to botulinum toxin therapy in humans and/or other mammals |
| 12/22/2009 | US7635483 Enzymatically inactive streptococcal C5a peptidase (SCP) conjugated or linked to one or more peptides; effective in immunizing a susceptible mammal against beta-hemolytic Streptococcus |
| 12/22/2009 | US7635482 Comprises nucleotide sequences coding polypeptides for diagnosis, prevention and treatment of meningitis, inflammations, bacterial and pneumonia infections |
| 12/22/2009 | US7635481 Ehrlichia canis bacterin, a carrier, an antibody response inducing agent and a cell-mediated immunity response inducing agent |
| 12/22/2009 | US7635480 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis |
| 12/22/2009 | US7635479 comprising fusion protein biodrug as antitumor agent; contains amino acid sequence from prokaryotic organism such as a Listeria species protein, an ActA protein, a Streptolysin protein; immunotherapy |
| 12/22/2009 | US7635478 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/22/2009 | US7635477 Parathyroid hormone receptor activation and stem and progenitor cell expansion |
| 12/22/2009 | US7635476 Chimpanzee monoclonal antibodies and antigen binding fragments including variable region peptides; bioassay for detection of hepatitis A virus; diagnosis, treatment and prevention of hepatitis; kits |
| 12/22/2009 | US7635475 Diabody-type bispecific antibody |
| 12/22/2009 | US7635473 comprising a humanized version of monoclonal antibody having light chain and heavy chain peptides, histidine buffering agent, mannitol tonicity agent; stable unit dosage form; Alzheimer's disease; reduce amyloid plaque |
| 12/22/2009 | US7635472 single chain antibody construct comprising binding domains specific for human CD3 and human CD19; anticarcinogenic biodrug for treating non-Hodgkin lymphoma |
| 12/22/2009 | US7635468 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine |
| 12/22/2009 | CA2354024C A recombinant vector expressing multiple costimulatory molecules and uses thereof |
| 12/22/2009 | CA2323607C Immunological methods to modulate myostatin in vertebrate subjects |
| 12/22/2009 | CA2243730C Streptococcus equi vaccine |